Enliven Therapeutics ELVN
NASDAQ ELVN
$41.52 -0.41 (-0.98%)
At close: Oct 23, 2026 · 4:00 PM EDT

Enliven Therapeutics (ELVN) Return on Sales [ROS] (2019 - 2026)

Updated

Analysis

Enliven Therapeutics (ELVN) Return on Sales [ROS] (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 24.35%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 37.86%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -3.52%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 20.57%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -133.21%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 28.37%
10 Enliven Therapeutics 3.04 Bn 753.67 Mn - -786.33%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -786.33%
Mar 31, 2026 -663.08%
Dec 31, 2025 -742.42%
Sep 30, 2025 -507.19%
Jun 30, 2025 -879.24%
Mar 31, 2025 -991.65%
Dec 31, 2024 -723.79%
Sep 30, 2024 -705.08%
Jun 30, 2024 -602.13%
Mar 31, 2024 -799.60%
Dec 31, 2023 -674.85%
Sep 30, 2023 -694.39%
Jun 30, 2023 -589.92%
Mar 31, 2023 -969.19%
Dec 31, 2022 -1,657.91%
Sep 30, 2022 -2,877.37%
Jun 30, 2022 -7,099.21%
Mar 31, 2022 -96,422.22%
Dec 31, 2021 -19,908.33%
Sep 30, 2021 -45,530.00%
API Access

Enliven Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ELVN&period=max&api_key=YOUR_API_KEY